NCT06214728

Use of Hyaluronic Acid Gel in Intraosseous Defects

Name: Clinical Trial NCT06214728
Creator: Bezmialem Vakif University
Keywords: Periodontitis, Hyaluronic acid gel application, procedure, clinical trial, Turkey

Assesment of Changes ın Clinical and Radiographic Parameters Following the Application of Local Hyaluronic acıd Gel as an Adjunct to Minimally Invasive Non-surgical Treatment of Intraosseous Defects

Bezmialem Vakif University·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Periodontitis
Drug/Device/Intervention: Hyaluronic acid gel application
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Bezmialem Vakif University
Location: Istanbul, Turkey

Timeline & enrollment

Phase: N/A
Start date: Mar 16, 2022
End date: May 12, 2023
Enrollment: 36 participants

Primary outcome

Intraosseous defect depth (INFRA)

Summary

Aim:  The aim of this randomised, parallel-arm, blinded, controlled clinical trial was to compare the clinical and radiographic efficacy of MINST with and without 0.8% HA gel application in the treatment of intraosseous defects.  Research Hypothesis:  The null hypothesis that there is no statistically significant difference in clinical and radiographic measurements between the use of HA gel in addition to MINST for the treatment of intraosseous defects and MINST treatment alone was tested.

ICD-10 classifications

Chronic periodontitisPeriodontosisAcute periodontitisChronic apical periodontitisPeriodontal disease, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06214728
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06214728 through Pure Global AI's free database. This phase not specified trial is sponsored by Bezmialem Vakif University and is currently Completed. The study focuses on Periodontitis. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.